• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于组织工程心脏瓣膜的细胞、支架和生物反应器:从基本概念到当代发展创新的历程。

Cells, scaffolds and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations.

机构信息

Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Via Giustiniani 2, 35128 Padova, Italy.

出版信息

Eur J Cardiothorac Surg. 2011 Apr;39(4):523-31. doi: 10.1016/j.ejcts.2010.07.030. Epub 2010 Dec 15.

DOI:10.1016/j.ejcts.2010.07.030
PMID:21163670
Abstract

The development of viable and functional tissue-engineered heart valves (TEHVs) is a challenge that, for almost two decades, the scientific community has been committed to face to create life-lasting prosthetic devices for treating heart valve diseases. One of the main drawbacks of tissue-based commercial substitutes, xenografts and homografts, is their lack of viability, and hence failure to grow, repair, and remodel. In adults, the average bioprostheses life span is around 13 years, followed by structural valve degeneration, such as calcification; in pediatric, mechanical valves are commonly used instead of biological substitutes, as in young patients, the mobilization of calcium, due to bone remodeling, accelerates the calcification process. Moreover, neither mechanical nor bioprostheses are able to follow children's body growth. Cell seeding and repopulation of acellular heart valve scaffolds, biological and polymeric, appears as a promising way to create a living valve. Biomechanical stimuli have significant impact on cell behavior including in vitro differentiation, and physiological hemodynamic conditioning has been found to promote new tissue development. These concepts have led scientists to design bioreactors to mimic the in vivo environment of heart valves. Many different types of somatic and stem cells have been tested for colonizing both the surface and the core of the valve matrix but controversial results have been achieved so far.

摘要

开发具有活力和功能的组织工程心脏瓣膜 (TEHV) 是科学界近二十年来一直致力于解决的挑战,以创建用于治疗心脏瓣膜疾病的持久假体装置。基于组织的商业替代品、异种移植物和同种移植物的主要缺点之一是它们缺乏活力,因此无法生长、修复和重塑。在成年人中,平均生物假体的使用寿命约为 13 年,随后会出现结构性瓣膜退化,如钙化;在儿科中,机械瓣膜通常被用于替代生物替代品,因为在年轻患者中,由于骨骼重塑导致的钙动员会加速钙化过程。此外,机械瓣膜和生物假体都无法适应儿童的身体生长。细胞接种和去细胞心脏瓣膜支架的再细胞化,无论是生物的还是聚合的,都似乎是创造活瓣的一种有前途的方法。生物力学刺激对细胞行为有重大影响,包括体外分化,并且已经发现生理血液动力学调节可以促进新组织的发育。这些概念促使科学家设计生物反应器来模拟心脏瓣膜的体内环境。已经测试了许多不同类型的体细胞和干细胞来定植瓣膜基质的表面和核心,但迄今为止取得的结果仍存在争议。

相似文献

1
Cells, scaffolds and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations.用于组织工程心脏瓣膜的细胞、支架和生物反应器:从基本概念到当代发展创新的历程。
Eur J Cardiothorac Surg. 2011 Apr;39(4):523-31. doi: 10.1016/j.ejcts.2010.07.030. Epub 2010 Dec 15.
2
Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.使用冷冻保存的脐血管细胞进行自体人体心脏瓣膜的组织工程。
Ann Thorac Surg. 2006 Jun;81(6):2207-16. doi: 10.1016/j.athoracsur.2005.12.073.
3
Review article: Tissue engineering of semilunar heart valves: current status and future developments.综述文章:半月形心脏瓣膜的组织工程:现状与未来发展
J Heart Valve Dis. 2004 Mar;13(2):272-80.
4
Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.周期性弯曲和层流协同加速间充质干细胞介导的工程组织形成:对工程心脏瓣膜组织的启示。
Biomaterials. 2006 Dec;27(36):6083-95. doi: 10.1016/j.biomaterials.2006.07.045. Epub 2006 Aug 23.
5
Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering.心脏瓣膜动力学的不断演变概念:发育、功能结构、病理生物学和组织工程的连续统一体。
Circulation. 2008 Oct 28;118(18):1864-80. doi: 10.1161/CIRCULATIONAHA.108.805911.
6
Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.微创植入活组织工程心脏瓣膜:从自体血管细胞到干细胞的综合方法。
J Am Coll Cardiol. 2010 Aug 3;56(6):510-20. doi: 10.1016/j.jacc.2010.04.024.
7
Bioreactors for development of tissue engineered heart valves.用于组织工程心脏瓣膜开发的生物反应器。
Ann Biomed Eng. 2010 Nov;38(11):3272-9. doi: 10.1007/s10439-010-0148-6. Epub 2010 Sep 4.
8
Clinical application of tissue engineered human heart valves using autologous progenitor cells.使用自体祖细胞的组织工程化人心脏瓣膜的临床应用
Circulation. 2006 Jul 4;114(1 Suppl):I132-7. doi: 10.1161/CIRCULATIONAHA.105.001065.
9
Tissue-engineered heart valve scaffolds.组织工程心脏瓣膜支架
Ann Thorac Cardiovasc Surg. 2009 Dec;15(6):362-7.
10
Heart valve tissue engineering.心脏瓣膜组织工程
Circ Res. 2005 Oct 14;97(8):743-55. doi: 10.1161/01.RES.0000185326.04010.9f.

引用本文的文献

1
Recent advances in innovative biomaterials for promoting bladder regeneration: processing and functionalization.促进膀胱再生的新型生物材料的最新进展:加工与功能化
Front Bioeng Biotechnol. 2025 Jan 6;12:1528658. doi: 10.3389/fbioe.2024.1528658. eCollection 2024.
2
Pre-vascularized porous gelatin-coated β-tricalcium phosphate scaffolds for bone regeneration: an in vivo and in vitro investigation.用于骨再生的预血管化多孔明胶包被β-磷酸三钙支架:一项体内和体外研究
In Vitro Cell Dev Biol Anim. 2025 Jan;61(1):67-80. doi: 10.1007/s11626-024-00973-5. Epub 2024 Oct 9.
3
3D-Cultured Adipose-Derived Stem Cell Spheres Using Calcium-Alginate Scaffolds for Osteoarthritis Treatment in a Mono-Iodoacetate-Induced Rat Model.
3D 培养的脂肪源性干细胞球,使用海藻酸钙支架,在碘乙酸盐诱导的大鼠模型中治疗骨关节炎。
Int J Mol Sci. 2023 Apr 11;24(8):7062. doi: 10.3390/ijms24087062.
4
Long-Term Examination of Degradation and In Vivo Biocompatibility of Some Mg-0.5Ca-xY Alloys in Sprague Dawley Rats.某些Mg-0.5Ca-xY合金在斯普拉格-道利大鼠体内的降解及生物相容性的长期研究
Materials (Basel). 2022 Aug 29;15(17):5958. doi: 10.3390/ma15175958.
5
Mechanical and Degradation Properties of Hybrid Scaffolds for Tissue Engineered Heart Valve (TEHV).用于组织工程心脏瓣膜(TEHV)的混合支架的力学性能和降解性能
J Funct Biomater. 2021 Mar 9;12(1):20. doi: 10.3390/jfb12010020.
6
3D Bioprinting Stem Cell Derived Tissues.3D生物打印干细胞衍生组织。
Cell Mol Bioeng. 2018 May 21;11(4):219-240. doi: 10.1007/s12195-018-0530-2. eCollection 2018 Aug.
7
Assessment of untreated fresh autologous pericardium as material for construction of heart valve: Result at 5 years.未经处理的新鲜自体心包作为心脏瓣膜构建材料的评估:5年结果。
Ann Card Anaesth. 2019 Jul-Sep;22(3):273-277. doi: 10.4103/aca.ACA_50_18.
8
Cardiac Valve Bioreactor for Physiological Conditioning and Hydrodynamic Performance Assessment.用于生理调节和流体动力学性能评估的心脏瓣膜生物反应器
Cardiovasc Eng Technol. 2019 Mar;10(1):80-94. doi: 10.1007/s13239-018-00382-2. Epub 2018 Oct 11.
9
Calcium Orthophosphate-Based Bioceramics.基于磷酸钙的生物陶瓷
Materials (Basel). 2013 Sep 6;6(9):3840-3942. doi: 10.3390/ma6093840.
10
Adhesive Peptide Sequences Regulate Valve Interstitial Cell Adhesion, Phenotype and Extracellular Matrix Deposition.黏附肽序列调节瓣膜间质细胞黏附、表型及细胞外基质沉积。
Cell Mol Bioeng. 2016 Dec;9(4):479-495. doi: 10.1007/s12195-016-0451-x. Epub 2016 Jun 10.